Skip to content

Study on the curative effect of Uighur medicine "Munziq and Musili" therapy on vitiligo based on real world research

Study on the curative effect of Uighur medicine "Munziq and Musili" therapy on vitiligo based on real world research

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082639
Enrollment
Unknown
Registered
2024-04-02
Start date
2024-04-02
Completion date
Unknown
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vitiligo

Interventions

test group:None

Sponsors

Xinjiang Kashi region Uighur medicine hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Fulfilled the criteria of the diagnosis of vitiligo in the 2014 consensus on the diagnosis of vitiligo; 2. Age = 8 years, = 65 years.

Exclusion criteria

Exclusion criteria: 1. Depigmentation, anemia nevus, albinism, pigment-free nevus, solar leukoplakia, etc. left after the skin rash recovers; 2. Patients with various tuberculosis, tumor, AIDS, syphilis, gonorrhea and other infectious diseases; 3. Heart failure, liver and kidney dysfunction; 4. Those who have taken steroids in the past two weeks or retinoic acid and other drugs in one week or who have taken steroids locally; 5. Pregnant and lactating women; 6. Those suspected or having a history of drug abuse; 7. Patients who have participated in other clinical trials in the past month.

Design outcomes

Primary

MeasureTime frame
White spot area;Pigment area;

Countries

China

Contacts

Public ContactAtikanmu·Wahefu

Xinjiang Kashi region Uighur medicine hospital

714397724@qq.com+86 136 1993 3439

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026